AK MEDICAL (1789.HK)
- Previous Close
5.640 - Open
5.690 - Bid 5.710 x --
- Ask 5.720 x --
- Day's Range
5.650 - 5.830 - 52 Week Range
3.490 - 6.460 - Volume
2,450,000 - Avg. Volume
7,605,942 - Market Cap (intraday)
6.385B - Beta (5Y Monthly) -0.62
- PE Ratio (TTM)
22.00 - EPS (TTM)
0.260 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield 0.07 (1.28%)
- Ex-Dividend Date Jun 23, 2025
- 1y Target Est
7.26
AK Medical Holdings Limited operates as an investment holding company that designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and offers surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is based in Beijing, the People's Republic of China.
www.ak-medical.netRecent News: 1789.HK
View MorePerformance Overview: 1789.HK
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1789.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1789.HK
View MoreValuation Measures
Market Cap
6.30B
Enterprise Value
5.30B
Trailing P/E
21.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.36
Price/Book (mrq)
2.22
Enterprise Value/Revenue
3.66
Enterprise Value/EBITDA
11.83
Financial Highlights
Profitability and Income Statement
Profit Margin
20.34%
Return on Assets (ttm)
5.93%
Return on Equity (ttm)
10.89%
Revenue (ttm)
1.35B
Net Income Avi to Common (ttm)
273.93M
Diluted EPS (ttm)
0.260
Balance Sheet and Cash Flow
Total Cash (mrq)
969.91M
Total Debt/Equity (mrq)
3.77%
Levered Free Cash Flow (ttm)
228.98M